Development of SPR206, a direct acting polymyxin antibiotic with reduced nephrotoxicity, to treat multidrug-resistant gram-negative bacterial pathogens
Ended Project Grant Awarded Last action
- Award ID
- W81XWH1910295
- Recipient
-
Spero Therapeutics, Inc. UEI NX34PL7NZW24
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $5,882,265
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Cambridge, MA 02139, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$12 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $5,882,277 |
Quick answers
Who received award W81XWH1910295?
W81XWH1910295 was awarded to Spero Therapeutics, Inc. by Defense Health Agency (Department of Defense) on July 15, 2019.
How much is award W81XWH1910295 worth?
$5,882,265 has been obligated on W81XWH1910295.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award